Medtronic is acquiring Affera Inc., a medical technology company focused on treating cardiac arrhythmias, for $925 million. While Medtronic declined Monday to share the sale price, analysts at Piper ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. At Catholic Health, advanced technology is changing how we ...

From a physiological perspective, heartbeats and breathing do not operate independently in the human body. Cardiac rhythm ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

Emerging cardiovascular technology, trends in ambulatory care, provider and payer partnerships, and value-based arrangements create strategic opportunities to address service demand and cost pressures ...

After a century of progress that cut deaths from cardiovascular disease in half, momentum has stalled. Heart disease and stroke remain the leading causes of death worldwide, mortality rates are ...

There is an indisputable trend toward minimally invasive, outpatient procedures in healthcare. Outpatient procedures help to alleviate burdens on the healthcare system, save patients time, money, and ...

Innovation is a powerful tool. Especially in the field of medicine, where it can save lives. The latest advancement, a new generation of noninvasive scanners, allow physicians the capability to ...

CHICAGO, Ill. (Ivanhoe Newswire) – This year, more than 356,000 people in the U.S. will experience a cardiac arrest – their heart will just stop. It’s caused by arrhythmias that prevent the heart from ...

February is American Heart Month and technology is helping in cardiac care. Experts at Cleveland Clinic weighs in. For more information, click here. Stay up-to-date: The latest headlines and weather ...

Johnson & Johnson will spend $16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division.The health care giant said Tuesday that it will pay $380 for each ...

New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often fail to make it to patients because all critical stakeholders are not ...